To identify new opportunities for treatment of diabetes
Establish HRI as a world-class early applied research centre
HRI MISSION
Feed Novo Nordisk pipeline with pre-projects driven by early applied research
Continue to remain world class by participation in scientific networks through research collaboration with top scientists and institutions
Development of new talents to support Novo Nordisk’s goal to treat and cure diabetes
HRI staff includes scientists, post docs, PhD students, master students, and research technicians working in diabetes research.
HRI is a part of the Novo Nordisk company, providing them with viable drug candidates for their diabetes product development pipeline.
